by Site Dev | Sep 16, 2022 | Breast Cancer
Early-Stage Breast Cancer Characteristics and Treatment Options Book Appointment A rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer...
by Site Dev | Dec 23, 2021 | Immunotherapy
Immunotherapy Treatments Bring Hope To Cancer Patients Book Appointment Immunotherapy is a treatment approach that harnesses the body’s immune system to target and attack a disease, such as cancer. Patients can receive immunotherapy through an injection, a pill or...
by Site Dev | Oct 26, 2021 | Clinical Trials, Prostate
Prostate Cancer Clinical Trials Contact Us 1) First Line Metastatic mCRPC: USO #19191: BMS CA209-7DX: A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer...
by Site Dev | Oct 26, 2021 | Clinical Trials, Multiple Myeloma
Multiple Myeloma Clinical Trials Contact Us 1)Relapsed/Refractory MM/ IONA: A prospective, non-interventional, multinational, observational study with Isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM) Send UsA Message LOCATION*...
by Site Dev | Oct 26, 2021 | Clinical Trials, Colorectal
Colorectal CancerClinical Trials Contact Us 1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C...
